A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15381932

Br. J. Cancer 2004 Oct 18 91 8 1434-41

Download in:

View as

Triples

General Info

PMID
15381932